Evidence map›Paper›PMID 32877242›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2020

Maternal low-protein diet on the last week of pregnancy contributes to insulin resistance and β-cell dysfunction in the mouse offspring.

Emilyn U Alejandro, Seokwon Jo, Brian Akhaphong, Pau Romaguera Llacer, Maya Gianchandani, Brigid Gregg, Sebastian D Parlee, Ormond A MacDougald, Ernesto Bernal-Mizrachi

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Epigenetic Regulation of Pancreas Development and Function.Advances in anatomy, embryology, and cell biology · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Emilyn U AlejandroDepartment of Integrative Biology and Physiology, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-7941-8439
Seokwon JoDepartment of Integrative Biology and Physiology, University of Minnesota, Minneapolis, Minnesota.
Brian AkhaphongDepartment of Integrative Biology and Physiology, University of Minnesota, Minneapolis, Minnesota.
Pau Romaguera LlacerDivision of Endocrinology, Metabolism and Diabetes, University of Miami, Miami, Florida.
Maya GianchandaniDivision of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, Brehm Center for Diabetes Research, University of Michigan Medical School, Ann Arbor, Michigan.
Brigid GreggDepartment of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan.
Sebastian D ParleeDepartment of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan.
Ormond A MacDougaldDepartment of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan.
Ernesto Bernal-MizrachiDivision of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, Brehm Center for Diabetes Research, University of Michigan Medical School, Ann Arbor, Michigan.ORCID 0000-0001-9997-3301
University of Michigan · USUniversity of Minnesota · USUniversity of Miami · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Martin G Myers · 2013 to 2026
$24.3M
Pilot and Feasibility (P and F) ProgramP30DK089503 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Kanakadurga Singer · 2010 to 2026
$20.3M
AKT/mTOR Signaling and Regulation of Cell Cycle in beta CellsR01DK073716 · NIDDK · WASHINGTON UNIVERSITY · PI BERNAL-MIZRACHI, ERNESTO · 2006 to 2022
$4.6M
Nutrient Signals and Programming of Pancreas DevelopmentR01DK084236 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BERNAL-MIZRACHI, ERNESTO · 2010 to 2018
$2.9M
The role of O-linked N-Acetylglucosamine Homeostasis in Pancreatic Beta-cell Development and FunctionR01DK115720 · NIDDK · UNIVERSITY OF MINNESOTA · PI ALEJANDRO, EMILYN · 2018 to 2022
$1.9M
Programming of beta-cells and Glucose Homeostasis by Maternal Metformin ExposureK08DK102526 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GREGG, BRIGID ELLEN · 2015 to 2021
$797k
O-linked-N-acetylglucosamine Post-translational Modification in Pancreatic Beta-cells Regulating ER Stress and Mitochondrial FunctionR21DK112144 · NIDDK · UNIVERSITY OF MINNESOTA · PI ALEJANDRO, EMILYN · 2017 to 2019
$576k
Innate Immune Complement System and Developmental Programming of Functional β Cell MassR21HD100840 · NICHD · UNIVERSITY OF MINNESOTA · PI ALEJANDRO, EMILYN, REGAL, JEAN F. · 2020 to 2021
$425k
mTOR signaling and regulation of alpha-cell mass and functionI01BX002728 · VA · MIAMI VA HEALTH CARE SYSTEM · PI BERNAL-MIZRACHI, ERNESTO · 2016 to 2025
–
BLRD VA I01 BX002728NICHD NIH HHS R21 HD100840NIDDK NIH HHS K08 DK102526NIDDK NIH HHS N02 DK062876NIDDK NIH HHS P30 DK020572NIDDK NIH HHS P30 DK089503NIDDK NIH HHS R01 DK073716NIDDK NIH HHS R01 DK084236NIDDK NIH HHS R01 DK115720NIDDK NIH HHS R21 DK112144NIH HHS DK073716NIH HHS R01DK084236NIH HHS R01DK115720NIH HHS R21DK112144NIH HHS R21HD100840NIH HHS RO1DK62876
6 · The paper itself

Abstract

Maternal low-protein diet (LP) throughout gestation affects pancreatic β-cell fraction of the offspring at birth, thus increasing their susceptibility to metabolic dysfunction and type 2 diabetes in adulthood. The present study sought to strictly examine the effects of LP during the last week of gestation (LP12.5) alone as a developmental window for β-cell programming and metabolic dysfunction in adulthood. Islet morphology analysis revealed normal β-cell fraction in LP12.5 newborns. Normal glucose tolerance was observed in 6- to 8-wk-old male and female LP12.5 offspring. However, male LP12.5 offspring displayed glucose intolerance and reduced insulin sensitivity associated with β-cell dysfunction with aging. High-fat diet exposure of metabolically normal 12-wk-old male LP12.5 induced glucose intolerance due to increased body weight, insulin resistance, and insufficient β-cell mass adaptation despite higher insulin secretion. Assessment of epigenetic mechanisms through microRNAs (miRs) by a real-time PCR-based microarray in islets revealed elevation in miRs that regulate insulin secretion (miRs 342, 143), insulin resistance (miR143), and obesity (miR219). In the islets, overexpression of miR143 reduced insulin secretion in response to glucose. In contrast to the model of LP exposure throughout pregnancy, islet protein levels of mTOR and pancreatic and duodenal homeobox 1 were normal in LP12.5 islets. Collectively, these data suggest that LP diet during the last week of pregnancy is critical and sufficient to induce specific and distinct developmental programming effects of tissues that control glucose homeostasis, thus causing permanent changes in specific set of microRNAs that may contribute to the overall vulnerability of the offspring to obesity, insulin resistance, and type 2 diabetes.

Indexed as

Diet, High-FatAdipose TissueAnimalsBlood GlucoseDiet, Protein-RestrictedFemaleGlucose Tolerance TestInsulin ResistanceInsulin-Secreting CellsInsulin SecretionMaternal Nutritional Physiological PhenomenaMiceMicroRNAsPregnancyPrenatal Exposure Delayed EffectsBlood GlucoseMicroRNAsMIRN143 microRNA, mousediabetesfetal nutrition disordersfetal programmingislet biologylow-protein dietβ-cell function

Identifiers

PMID32877242
PMCPMC7717124
OpenAlexW3081638207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.